Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells - PubMed (original) (raw)
. 2011 Sep;10(9):1553-62.
doi: 10.1158/1535-7163.MCT-11-0067. Epub 2011 Jul 12.
Swetha Perera, Anna Mariana, Hui Lau, Maggie P C Ma, Jayne Gilbert, Nigel C Jones, Christopher P Gordon, Kelly A Young, Andrew Morokoff, Jennette Sakoff, Terence J O'Brien, Adam McCluskey, Phillip J Robinson
Affiliations
- PMID: 21750222
- DOI: 10.1158/1535-7163.MCT-11-0067
Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells
Megan Chircop et al. Mol Cancer Ther. 2011 Sep.
Abstract
Inhibitors of mitotic proteins such as Aurora kinase and polo-like kinase have shown promise in preclinical or early clinical development for cancer treatment. We have reported that the MiTMAB class of dynamin small molecule inhibitors are new antimitotic agents with a novel mechanism of action, blocking cytokinesis. Here, we examined 5 of the most potent of a new series of dynamin GTPase inhibitors called dynoles. They all induced cytokinesis failure at the point of abscission, consistent with inhibition of dynamin while not affecting other cell cycle stages. All 5 dynoles inhibited cell proliferation (MTT and colony formation assays) in 11 cancer cell lines. The most potent GTPase inhibitor, dynole 34-2, also induced apoptosis, as revealed by cell blebbing, DNA fragmentation, and PARP cleavage. Cell death was induced specifically following cytokinesis failure, suggesting that dynole 34-2 selectively targets dividing cells. Dividing HeLa cells were more sensitive to the antiproliferative properties of all 5 dynoles compared with nondividing cells, and nontumorigenic fibroblasts were less sensitive to cell death induced by dynole 34-2. Thus, the dynoles are a second class of dynamin GTPase inhibitors, with dynole 34-2 as the lead compound, that are novel antimitotic compounds acting specifically at the abscission stage.
Similar articles
- Dynamin inhibitors induce caspase-mediated apoptosis following cytokinesis failure in human cancer cells and this is blocked by Bcl-2 overexpression.
Joshi S, Braithwaite AW, Robinson PJ, Chircop M. Joshi S, et al. Mol Cancer. 2011 Jun 28;10:78. doi: 10.1186/1476-4598-10-78. Mol Cancer. 2011. PMID: 21708043 Free PMC article. - The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells.
Joshi S, Perera S, Gilbert J, Smith CM, Mariana A, Gordon CP, Sakoff JA, McCluskey A, Robinson PJ, Braithwaite AW, Chircop M. Joshi S, et al. Mol Cancer Ther. 2010 Jul;9(7):1995-2006. doi: 10.1158/1535-7163.MCT-10-0161. Epub 2010 Jun 22. Mol Cancer Ther. 2010. PMID: 20571068 - Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
Hill TA, Gordon CP, McGeachie AB, Venn-Brown B, Odell LR, Chau N, Quan A, Mariana A, Sakoff JA, Chircop M, Robinson PJ, McCluskey A. Hill TA, et al. J Med Chem. 2009 Jun 25;52(12):3762-73. doi: 10.1021/jm900036m. J Med Chem. 2009. PMID: 19459681 - Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors.
Harper CB, Popoff MR, McCluskey A, Robinson PJ, Meunier FA. Harper CB, et al. Trends Cell Biol. 2013 Feb;23(2):90-101. doi: 10.1016/j.tcb.2012.10.007. Epub 2012 Nov 17. Trends Cell Biol. 2013. PMID: 23164733 Review. - Antimitotic inhibitors.
Campos SM, Dizon DS. Campos SM, et al. Hematol Oncol Clin North Am. 2012 Jun;26(3):607-28, viii-ix. doi: 10.1016/j.hoc.2012.01.007. Epub 2012 Mar 23. Hematol Oncol Clin North Am. 2012. PMID: 22520982 Review.
Cited by
- Small molecules targeting endocytic uptake and recycling pathways.
Placidi G, Mattu C, Ciardelli G, Campa CC. Placidi G, et al. Front Cell Dev Biol. 2023 Mar 10;11:1125801. doi: 10.3389/fcell.2023.1125801. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36968200 Free PMC article. Review. - Inhibition of clathrin by pitstop 2 activates the spindle assembly checkpoint and induces cell death in dividing HeLa cancer cells.
Smith CM, Haucke V, McCluskey A, Robinson PJ, Chircop M. Smith CM, et al. Mol Cancer. 2013 Jan 17;12:4. doi: 10.1186/1476-4598-12-4. Mol Cancer. 2013. PMID: 23327284 Free PMC article. - Prodrugs of the Archetypal Dynamin Inhibitor Bis-T-22.
Odell LR, Robertson MJ, Young KA, McGeachie AB, Quan A, Robinson PJ, McCluskey A. Odell LR, et al. ChemMedChem. 2022 Dec 16;17(24):e202200400. doi: 10.1002/cmdc.202200400. Epub 2022 Nov 9. ChemMedChem. 2022. PMID: 36351775 Free PMC article. - Targeting the Mitotic Catastrophe Signaling Pathway in Cancer.
Mc Gee MM. Mc Gee MM. Mediators Inflamm. 2015;2015:146282. doi: 10.1155/2015/146282. Epub 2015 Sep 27. Mediators Inflamm. 2015. PMID: 26491220 Free PMC article. Review. - The Dynamin 2 inhibitor Dynasore affects the actin filament distribution during mouse early embryo development.
Wang QC, Liu J, Duan X, Cui XS, Kim NH, Xiong B, Sun SC. Wang QC, et al. J Reprod Dev. 2015;61(1):49-53. doi: 10.1262/jrd.2014-079. Epub 2014 Nov 21. J Reprod Dev. 2015. PMID: 25421092 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources